首页> 外文期刊>Sexually transmitted diseases >Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy
【24h】

Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy

机译:开始勃起功能障碍药物治疗的患者的性病史和性传播感染筛查

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Erectile dysfunction medications are being prescribed frequently; however, little is known about the amount of sexual health screening occurring in this setting. Methods: A retrospective cohort study evaluating sexual health and sexually transmitted infection screening occurring in veterans receiving initial erectile dysfunction medication prescription was conducted. Results: A total of 252 patients received initial erectile dysfunction medication prescriptions between October 1, 2009, and December 31, 2009; had at least 1 health care provider visit 12 months before the date of initial prescription; and had no documentation of previous erectile dysfunction medication use. Approximately 3% of these patients had any aspect of a sexual history recorded in the 24 months surrounding initial erectile dysfunction medication prescription. Sexually transmitted infection screening was 9.9% for syphilis, 4.8% for HIV, and 4.3% for gonorrhea/chlamydia before prescription, with only a slight increase in HIV screening after prescription. Conclusions: Minimal sexual health assessment is being performed during the time surrounding initial prescription of erectile dysfunction medication. Further work needs to evaluate patient and provider barriers to basic elements of sexual health care, such as taking sexual histories or screening for sexually transmitted infections.
机译:背景:经常使用勃起功能障碍药物;然而,对于这种情况下发生的性健康筛查的数量知之甚少。方法:进行了一项回顾性队列研究,评估接受初始勃起功能障碍药物处方的退伍军人的性健康和性传播感染筛查。结果:在2009年10月1日至2009年12月31日期间,共有252例患者接受了最初的勃起功能障碍药物处方;在初次开药之日前12个月至少有1位医疗保健提供者就诊;并且没有以前使用勃起功能障碍药物的记录。这些患者中约有3%在最初的勃起功能障碍药物处方后的24个月内有任何性病史记录。处方前进行性传播感染筛查的梅毒为9.9%,艾滋病毒为4.8%,淋病/衣原体为4.3%,处方后的HIV筛查仅略有增加。结论:在勃起功能障碍药物的初始处方前后,对性健康的评估最少。进一步的工作需要评估患者和医疗服务提供者在性保健基本要素方面的障碍,例如接受性病史或筛查性传播感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号